Jianqin Shan

Statistics

Publications

Citations

10K

H-Index

Active since

2000

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Jianqin Shan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and chronic myeloid leukemia therapy.

Publications per year

2000–2014

Publications

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Hagop M. Kantarjian, Yasuhiro Oki, Guillermo Garcia‐Manero et al. · Blood · 2006 · 689 citations · Full text

Medicine, Oncology, Pharmacology +16

Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia

Hagop M. Kantarjian, Deborah A. Thomas, Susan O’Brien et al. · Cancer · 2004 · 632 citations

Medicine, Oncology, Pharmacology +12

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:

Hagop M. Kantarjian, Susan O’Brien, Jörge E. Cortes et al. · Cancer · 2006 · 607 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Deborah A. Thomas, Stefan Faderl, Susan O’Brien et al. · Cancer · 2006 · 564 citations

Medicine, Immunology, Oncology +14

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

Hagop M. Kantarjian, Susan O’Brien, Farhad Ravandi et al. · Cancer · 2008 · 485 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

1–5 of 66